In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Guidant's Loss of Innocence

Executive Summary

Since its 1994 spin off, Guidant has built itself into one of the leading cardiovascular device companies through a deft technology innovation. But a series of recent missteps, most visibly in its AAA graft business but most importantly in its drug-eluting stent business, has caused this former start-up to grow up quickly. But Guidant officials counter that the AAA problems will quickly be put behind and that the drug-eluting stent program will emerge a winner, every bit as strong as its traditional bare metal stent business and its currently robust cardiac rhythm management business.

Related Content

How To Fix A Guidant: Boston Scientific's Tobin Opens Playbook
Elephant Cha-Cha: The J&J/Guidant Deal
Elephant Cha-Cha: The J&J/Guidant Deal
Biosensors: Small Company Turns Major Dealmaker
Guidant Shines Light on Vulnerable Plaque with Miravant Deal
Cameron Health and the Revolution From Below
Next Drug Stent Trials: Medtronic Goes to Europe, Guidant Stays Home
Guidant: The New Rules of the Device Game
Staying the Course in Endovascular AAA Repair
Guidant: The New Rules of the Device Game


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts